Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fri, 02/17/23 - 09:44 am
Tags:
Fresenius Kabi
,
Stimufend
,
pegfilgrastim
,
biosimilars
,
Neulasta
,
Amgen
,
cancer
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
Thu, 02/16/23 - 04:49 pm
Tags:
biosimilars
,
PBMs
,
physicians
,
AbbVie
,
Humira
,
Amgen
,
Amjevita
Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Thu, 02/16/23 - 11:25 am
Tags:
Amgen
,
bond
,
M&A
,
Horizon Therapeutics
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
Tags:
layoffs
,
Grifols
,
Frequency Therapeutics
,
Eliem Therapeutics
,
Aligos Therapeutics
,
Thermo Fisher Scientific
,
Magenta Therapeutics
,
Eisai
,
Amgen
,
Y-mAbs Therapeutics
,
Century Therapeutics
,
Elevation Oncology
,
Calithera Biosciences
,
Editas Medicine
,
Verily
,
Abzena
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Fierce Biotech
Wed, 02/1/23 - 10:32 pm
Tags:
layoffs
,
Amgen
,
Merck KGaA
,
TCR2 Therapeutics
,
Moderna Therapeutics
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Wed, 02/1/23 - 10:41 am
Tags:
Amgen
,
Amjevita
,
AbbVie
,
Humira
,
biosimilars
,
drug pricing
Amgen launches Humira biosimilar, releases Q4 earnings report
Medical Marketing and Media
Tue, 01/31/23 - 11:21 pm
Tags:
Amgen
,
Humira
,
biosimilars
,
earnings
,
AbbVie
,
Amjevita
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
BioPharma Dive
Tue, 01/31/23 - 12:37 pm
Tags:
AbbVie
,
Humira
,
biosimilars
,
Amgen
Amgen commits $8m to improve clinical trial diversity
Outsourcing Pharma
Tue, 01/31/23 - 10:24 am
Tags:
Amgen
,
clinical trials
,
clinical trial diversity
,
Bristol Myers Squibb
,
Winn Award
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Fierce Pharma
Mon, 01/30/23 - 10:54 am
Tags:
Amgen
,
layoffs
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Tags:
Elizabeth Warren
,
Senate
,
FTC
,
M&A
,
Amgen
,
Horizon Therapeutics
,
Indivior
,
Opiant Pharmaceuticals
Amgen extends autoimmune pact with small Michigan biotech
Endpoints
Wed, 01/18/23 - 11:02 pm
Tags:
Amgen
,
autoimmune disease
,
Evoq Therapeutics
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Tags:
Amgen
,
Humira
,
biosimilars
,
adalimumab
,
Amjevita
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
Tags:
NewAmsterdam Pharma
,
Amgen
,
CETP inhibitors
,
obicetrapib
,
clinical trials
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
Tags:
pharma stocks
,
Amgen
,
BeiGene
,
Bristol Myers Squibb
,
Gilead Sciences
,
Lantheus Holdings
,
Madrigal Pharmaceuticals
,
Merck
,
Moderna Therapeutics
,
Novo Nordisk
,
Prometheus Biosciences
,
Roche
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
Tags:
M&A
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
GSK
,
Ipsen
,
Merck
,
Pfizer
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
BioSpace
Tue, 01/10/23 - 06:43 pm
Tags:
Amgen
,
JPMHC 2023
,
M&A
,
biosimilars
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Fierce Biotech
Thu, 01/5/23 - 04:42 pm
Tags:
Amgen
,
antibody-drug conjugate
,
Synaffix
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Tags:
Amgen
,
Sanofi
,
Regeneron
,
Supreme Court
,
legal
,
innovation
,
patents
,
Repatha
,
Praluent
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
Tags:
antibody-drug conjugate
,
Merck
,
LegoChem Biosciences
,
Mersana
,
Amgen
,
GSK
,
Janssen
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.